{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T08:56:22Z","timestamp":1771232182636,"version":"3.50.1"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T00:00:00Z","timestamp":1594944000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T00:00:00Z","timestamp":1594944000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1007\/s40618-020-01349-8","type":"journal-article","created":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T15:46:38Z","timestamp":1595000798000},"page":"567-580","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Effects of oral contraceptives on serum concentrations of adipokines and adiposity indices of women with polycystic ovary syndrome: a randomized controlled trial"],"prefix":"10.1007","volume":"44","author":[{"given":"M.","family":"Amiri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Rahmati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Hedayati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Nahidi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Ramezani Tehrani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,7,17]]},"reference":[{"issue":"2","key":"1349_CR1","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.fertnstert.2008.06.035","volume":"91","author":"R Azziz","year":"2009","unstructured":"Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Futterweit W, Janssen OE, Legro RS, Norman RJ, Taylor AE (2009) The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril 91(2):456\u2013488","journal-title":"Fertil Steril"},{"issue":"10","key":"1349_CR2","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1111\/j.1471-0528.2006.00990.x","volume":"113","author":"R Pasquali","year":"2006","unstructured":"Pasquali R, Gambineri A, Pagotto U (2006) The impact of obesity on reproduction in women with polycystic ovary syndrome. BJOG Int J Obstet Gynaecol 113(10):1148\u20131159","journal-title":"BJOG Int J Obstet Gynaecol"},{"issue":"3","key":"1349_CR3","doi-asserted-by":"publisher","first-page":"346","DOI":"10.4183\/aeb.2018.346","volume":"14","author":"AA Boshku","year":"2018","unstructured":"Boshku AA, Panova DI, Ivanovska BZ (2018) Adiponectin as a serum marker of adipose tissue dysfunction in women with polycystic ovary syndrome: correlation with indicators of metabolic disturbances. Acta Endocrinologica (Bucharest) 14(3):346","journal-title":"Acta Endocrinologica (Bucharest)"},{"key":"1349_CR4","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.diabres.2017.06.011","volume":"130","author":"D Macut","year":"2017","unstructured":"Macut D, Bjeki\u0107-Macut J, Raheli\u0107 D, Dokni\u0107 M (2017) Insulin and the polycystic ovary syndrome. Diabetes Res Clin Pract 130:163\u2013170","journal-title":"Diabetes Res Clin Pract"},{"issue":"3","key":"1349_CR5","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s40618-019-01108-4","volume":"43","author":"M Bicer","year":"2020","unstructured":"Bicer M, Alarslan P, Guler A, Demir I, Aslanipour B, Calan M (2020) Elevated circulating levels of secreted frizzled-related protein 4 in relation to insulin resistance and androgens in women with polycystic ovary syndrome. J Endocrinol Invest 43(3):305\u2013313","journal-title":"J Endocrinol Invest"},{"issue":"5","key":"1349_CR6","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1080\/09513590.2018.1534096","volume":"35","author":"DP Baldani","year":"2019","unstructured":"Baldani DP, Skrgatic L, Kasum M, Zlopasa G, Kralik Oguic S, Herman M (2019) Altered leptin, adiponectin, resistin and ghrelin secretion may represent an intrinsic polycystic ovary syndrome abnormality. Gynecol Endocrinol 35(5):401\u2013405","journal-title":"Gynecol Endocrinol"},{"issue":"9","key":"1349_CR7","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1007\/s40618-018-0831-2","volume":"41","author":"S Kahraman","year":"2018","unstructured":"Kahraman S, Altinova AE, Yalcin MM, Gulbahar O, Arslan B, Akturk M, Cakir N, Toruner F (2018) Association of serum betatrophin with fibroblast growth factor-21 in women with polycystic ovary syndrome. J Endocrinol Invest 41(9):1069\u20131074","journal-title":"J Endocrinol Invest"},{"issue":"3","key":"1349_CR8","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1677\/joe.1.07070","volume":"192","author":"A Corbould","year":"2007","unstructured":"Corbould A (2007) Chronic testosterone treatment induces selective insulin resistance in subcutaneous adipocytes of women. J Endocrinol 192(3):585\u2013594","journal-title":"J Endocrinol"},{"issue":"4","key":"1349_CR9","doi-asserted-by":"publisher","first-page":"281","DOI":"10.3109\/09513590903247873","volume":"26","author":"D Glintborg","year":"2010","unstructured":"Glintborg D, Andersen M (2010) An update on the pathogenesis, inflammation, and metabolism in hirsutism and polycystic ovary syndrome. Gynecol Endocrinol 26(4):281\u2013296","journal-title":"Gynecol Endocrinol"},{"key":"1349_CR10","unstructured":"Bedi D (2007) Regulation of adiponectin secretion by endothelin-1 and myosin II"},{"issue":"4","key":"1349_CR11","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1038\/oby.2005.74","volume":"13","author":"M Degawa-Yamauchi","year":"2005","unstructured":"Degawa-Yamauchi M, Moss KA, Bovenkerk JE, Shankar SS, Morrison CL, Lelliott CJ, Vidal-Puig A, Jones R, Considine RV (2005) Regulation of adiponectin expression in human adipocytes: effects of adiposity, glucocorticoids, and tumor necrosis factor \u03b1. Obes Res 13(4):662\u2013669","journal-title":"Obes Res"},{"issue":"3","key":"1349_CR12","doi-asserted-by":"publisher","first-page":"C355","DOI":"10.1152\/ajpcell.00019.2013","volume":"305","author":"A Barbosa-Desongles","year":"2013","unstructured":"Barbosa-Desongles A, Hern\u00e1ndez C, Sim\u00f3 R, Selva DM (2013) Testosterone induces cell proliferation and cell cycle gene overexpression in human visceral preadipocytes. Am J Physiol Cell Physiol 305(3):C355\u2013C359","journal-title":"Am J Physiol Cell Physiol"},{"issue":"9","key":"1349_CR13","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/j.steroids.2013.05.001","volume":"78","author":"G Chazenbalk","year":"2013","unstructured":"Chazenbalk G, Singh P, Irge D, Shah A, Abbott DH, Dumesic DA (2013) Androgens inhibit adipogenesis during human adipose stem cell commitment to preadipocyte formation. Steroids 78(9):920\u2013926","journal-title":"Steroids"},{"issue":"5","key":"1349_CR14","doi-asserted-by":"publisher","first-page":"R219","DOI":"10.1530\/REP-14-0435","volume":"149","author":"PM Spritzer","year":"2015","unstructured":"Spritzer PM, Lecke SB, Satler F, Morsch DM (2015) Adipose tissue dysfunction, adipokines, and low-grade chronic inflammation in polycystic ovary syndrome. Reproduction 149(5):R219\u2013R227","journal-title":"Reproduction"},{"issue":"1","key":"1349_CR15","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/oby.2008.491","volume":"17","author":"M Luque-Ram\u00edrez","year":"2009","unstructured":"Luque-Ram\u00edrez M, \u00c1lvarez-Blasco F, Escobar-Morreale HF (2009) Antiandrogenic contraceptives increase serum adiponectin in obese polycystic ovary syndrome patients. Obesity 17(1):3\u20139","journal-title":"Obesity"},{"issue":"8","key":"1349_CR16","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1007\/s40618-014-0103-8","volume":"37","author":"D Glintborg","year":"2014","unstructured":"Glintborg D, Mumm H, Altinok ML, Richelsen B, Bruun JM, Andersen M (2014) Adiponectin, interleukin-6, monocyte chemoattractant protein-1, and regional fat mass during 12-month randomized treatment with metformin and\/or oral contraceptives in polycystic ovary syndrome. J Endocrinol Invest 37(8):757\u2013764","journal-title":"J Endocrinol Invest"},{"issue":"2","key":"1349_CR17","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/j.fertnstert.2008.07.008","volume":"92","author":"N Sa\u011fs\u00f6z","year":"2009","unstructured":"Sa\u011fs\u00f6z N, Orbak Z, Noyan V, Y\u00fccel A, U\u00e7ar B, Y\u0131ld\u0131z L (2009) The effects of oral contraceptives including low-dose estrogen and drospirenone on the concentration of leptin and ghrelin in polycystic ovary syndrome. Fertil Steril 92(2):660\u2013666","journal-title":"Fertil Steril"},{"issue":"1","key":"1349_CR18","first-page":"185","volume":"32","author":"SA Morrison","year":"2017","unstructured":"Morrison SA, Goss AM, Azziz R, Raju DA, Gower BA (2017) Peri-muscular adipose tissue may play a unique role in determining insulin sensitivity\/resistance in women with polycystic ovary syndrome. Hum Reprod 32(1):185\u2013192","journal-title":"Hum Reprod"},{"issue":"5","key":"1349_CR19","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1159\/000074037","volume":"60","author":"I Sahin","year":"2003","unstructured":"Sahin I, Serter R, Karakurt F, Demirbas B, Guler S, Culha C, Taskapan C, Aral Y (2003) Leptin levels increase during flutamide therapy in women with polycystic ovary syndrome. Hormone Res Paediatr 60(5):232\u2013236","journal-title":"Hormone Res Paediatr"},{"issue":"6","key":"1349_CR20","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.contraception.2004.01.003","volume":"69","author":"T Rechberger","year":"2004","unstructured":"Rechberger T, Tomaszewski J, Pieprzowska-Bia\u0142ek A, Kulik-Rechberger B, Skorupski P (2004) Serum resistin levels in women taking combined oral contraceptives containing desogestrel or gestodene. Contraception 69(6):477\u2013480","journal-title":"Contraception"},{"issue":"8","key":"1349_CR21","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1034\/j.1600-0412.2003.00189.x","volume":"82","author":"FM Koyuncu","year":"2003","unstructured":"Koyuncu FM, Kuscu NK, Var A, Onur E (2003) Leptin levels in patients with polycystic ovary syndrome in response to two different oral contraceptive treatments. Acta Obstet Gynecol Scand 82(8):767\u2013768","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"4","key":"1349_CR22","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1016\/j.fertnstert.2012.06.035","volume":"98","author":"SM Bhattacharya","year":"2012","unstructured":"Bhattacharya SM, Jha A (2012) Comparative study of the therapeutic effects of oral contraceptive pills containing desogestrel, cyproterone acetate, and drospirenone in patients with polycystic ovary syndrome. Fertil Steril 98(4):1053\u20131059","journal-title":"Fertil Steril"},{"issue":"5","key":"1349_CR23","first-page":"358","volume":"36","author":"E Carmina","year":"2013","unstructured":"Carmina E (2013) Oral contraceptives and cardiovascular risk in women with polycystic ovary syndrome. J Endocrinol Invest 36(5):358\u2013363","journal-title":"J Endocrinol Invest"},{"issue":"10","key":"1349_CR24","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1016\/j.metabol.2015.06.011","volume":"64","author":"D Glintborg","year":"2015","unstructured":"Glintborg D, Sidelmann JJ, Altinok ML, Mumm H, Andersen M (2015) Increased thrombin generation in women with polycystic ovary syndrome: a pilot study on the effect of metformin and oral contraceptives. Metabolism 64(10):1272\u20131278","journal-title":"Metabolism"},{"issue":"3","key":"1349_CR25","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1210\/jc.2014-3196","volume":"100","author":"BO Yildiz","year":"2015","unstructured":"Yildiz BO (2015) Approach to the patient: contraception in women with polycystic ovary syndrome. J Clin Endocrinol Metabol 100(3):794\u2013802","journal-title":"J Clin Endocrinol Metabol"},{"issue":"1","key":"1349_CR26","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1741-7015-8-18","volume":"8","author":"KF Schulz","year":"2010","unstructured":"Schulz KF, Altman DG, Moher D (2010) CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMC Med 8(1):18","journal-title":"BMC Med"},{"issue":"11","key":"1349_CR27","doi-asserted-by":"publisher","first-page":"4237","DOI":"10.1210\/jc.2006-0178","volume":"91","author":"R Azziz","year":"2006","unstructured":"Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Futterweit W, Janssen OE, Legro RS, Norman RJ, Taylor AE (2006) Criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an androgen excess society guideline. J Clin Endocrinol Metabol 91(11):4237\u20134245","journal-title":"J Clin Endocrinol Metabol"},{"issue":"2","key":"1349_CR28","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1093\/humupd\/dmr042","volume":"18","author":"H Escobar-Morreale","year":"2012","unstructured":"Escobar-Morreale H, Carmina E, Dewailly D, Gambineri A, Kelestimur F, Moghetti P, Pugeat M, Qiao J, Wijeyaratne C, Witchel S (2012) Epidemiology, diagnosis and management of hirsutism: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome Society. Human Reprod Update 18(2):146\u2013170","journal-title":"Human Reprod Update"},{"issue":"1","key":"1349_CR29","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.pdpdt.2010.01.003","volume":"7","author":"X-L Wang","year":"2010","unstructured":"Wang X-L, Wang H-W, Zhang L-L, Guo M-X, Huang Z (2010) Topical ALA PDT for the treatment of severe acne vulgaris. Photodiagn Photodyn Ther 7(1):33\u201338","journal-title":"Photodiagn Photodyn Ther"},{"issue":"3","key":"1349_CR30","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1111\/j.1365-2133.1977.tb15179.x","volume":"97","author":"E Ludwig","year":"1977","unstructured":"Ludwig E (1977) Classification of the types of androgenetic alopecia (common baldness) occurring in the female sex. Br J Dermatol 97(3):247\u2013254","journal-title":"Br J Dermatol"},{"issue":"8","key":"1349_CR31","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1093\/clinchem\/33.8.1372","volume":"33","author":"TJ WIlke","year":"1987","unstructured":"WIlke TJ, Utley DJ (1987) Total testosterone, free-androgen index, calculated free testosterone, and free testosterone by analog RIA compared in hirsute women and in otherwise-normal women with altered binding of sex-hormone-binding globulin. Clin Chem 33(8):1372\u20131375","journal-title":"Clin Chem"},{"issue":"1","key":"1349_CR32","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1758-5996-3-18","volume":"3","author":"A Zadeh-Vakili","year":"2011","unstructured":"Zadeh-Vakili A, Tehrani FR, Hosseinpanah F (2011) Waist circumference and insulin resistance: a community based cross sectional study on reproductive aged Iranian women. Diabetol Metabol Syndr 3(1):18","journal-title":"Diabetol Metabol Syndr"},{"issue":"11","key":"1349_CR33","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.4158\/EP15748.DSC","volume":"21","author":"NF Goodman","year":"2015","unstructured":"Goodman NF, Cobin RH, Futterweit W, Glueck JS, Legro RS, Carmina E (2015) American Association of Clinical Endocrinologists, American College of Endocrinology, and androgen excess and PCOS society disease state clinical review: guide to the best practices in the evaluation and treatment of polycystic ovary syndrome-part 1. Endocr Pract 21(11):1291\u20131300","journal-title":"Endocr Pract"},{"issue":"6","key":"1349_CR34","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1001\/jama.1968.03140060001001","volume":"203","author":"L Chiazze","year":"1968","unstructured":"Chiazze L, Brayer FT, Macisco JJ, Parker MP, Duffy BJ (1968) The length and variability of the human menstrual cycle. JAMA 203(6):377\u2013380","journal-title":"JAMA"},{"issue":"6","key":"1349_CR35","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1038\/ijo.2008.11","volume":"32","author":"A Romero-Corral","year":"2008","unstructured":"Romero-Corral A, Somers VK, Sierra-Johnson J, Thomas RJ, Collazo-Clavell M, Jec Korinek, Allison TG, Batsis J, Sert-Kuniyoshi F, Lopez-Jimenez F (2008) Accuracy of body mass index in diagnosing obesity in the adult general population. Int J Obes 32(6):959\u2013966","journal-title":"Int J Obes"},{"issue":"1","key":"1349_CR36","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/1471-2261-5-26","volume":"5","author":"HS Kahn","year":"2005","unstructured":"Kahn HS (2005) The\u201d lipid accumulation product\u201d performs better than the body mass index for recognizing cardiovascular risk: a population-based comparison. BMC Cardiovasc Disord 5(1):26","journal-title":"BMC Cardiovasc Disord"},{"key":"1349_CR37","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.ejogrb.2016.08.011","volume":"205","author":"S Behboudi-Gandevani","year":"2016","unstructured":"Behboudi-Gandevani S, Tehrani FR, Cheraghi L, Azizi F (2016) Could \u201ca body shape index\u201d and \u201cwaist to height ratio\u201d predict insulin resistance and metabolic syndrome in polycystic ovary syndrome? Eur J Obstet Gynecol Reprod Biol 205:110\u2013114","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"2","key":"1349_CR38","first-page":"746","volume":"46","author":"G Li","year":"2017","unstructured":"Li G, Taljaard M, Van den Heuvel ER, Levine MA, Cook DJ, Wells GA, Devereaux PJ, Thabane L (2017) An introduction to multiplicity issues in clinical trials: the what, why, when and how. Int J Epidemiol 46(2):746\u2013755","journal-title":"Int J Epidemiol"},{"issue":"6","key":"1349_CR39","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1177\/00131640021970961","volume":"60","author":"I Berkovits","year":"2000","unstructured":"Berkovits I, Hancock GR, Nevitt J (2000) Bootstrap resampling approaches for repeated measure designs: relative robustness to sphericity and normality violations. Educ Psychol Measur 60(6):877\u2013892","journal-title":"Educ Psychol Measur"},{"issue":"1","key":"1349_CR40","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/1471-2288-13-100","volume":"13","author":"Y Guo","year":"2013","unstructured":"Guo Y, Logan HL, Glueck DH, Muller KE (2013) Selecting a sample size for studies with repeated measures. BMC Med Res Methodol 13(1):100","journal-title":"BMC Med Res Methodol"},{"issue":"2","key":"1349_CR41","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1159\/000336664","volume":"30","author":"E Scarpellini","year":"2012","unstructured":"Scarpellini E, Tack J (2012) Obesity and metabolic syndrome: an inflammatory condition. Dig Dis 30(2):148\u2013153","journal-title":"Dig Dis"},{"issue":"4","key":"1349_CR42","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.metabol.2012.08.012","volume":"62","author":"K Michalakis","year":"2013","unstructured":"Michalakis K, Mintziori G, Kaprara A, Tarlatzis BC, Goulis DG (2013) The complex interaction between obesity, metabolic syndrome and reproductive axis: a narrative review. Metabolism 62(4):457\u2013478","journal-title":"Metabolism"},{"key":"1349_CR43","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.ejogrb.2015.06.022","volume":"192","author":"S-H Shen","year":"2015","unstructured":"Shen S-H, Shen S-Y, Liou T-H, Hsu M-I, Y-cI Chang, Cheng C-Y, Hsu C-S, Tzeng C-R (2015) Obesity and inflammatory biomarkers in women with polycystic ovary syndrome. Eur J Obstet Gynecol Reprod Biol 192:66\u201371","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"5","key":"1349_CR44","doi-asserted-by":"publisher","first-page":"390","DOI":"10.3109\/09513590.2015.1126708","volume":"32","author":"JKY Ko","year":"2016","unstructured":"Ko JKY, Li HWR, Lam KSL, Tam S, Lee VCY, Yeung TWY, Ho PC, Ng EHY (2016) Serum adiponectin is independently associated with the metabolic syndrome in Hong Kong, Chinese women with polycystic ovary syndrome. Gynecol Endocrinol 32(5):390\u2013394","journal-title":"Gynecol Endocrinol"},{"key":"1349_CR45","doi-asserted-by":"crossref","unstructured":"Abate N, S Sallam H, Rizzo M, Nikolic D, Obradovic M, Bjelogrlic P, R Isenovic E (2014) Resistin: an inflammatory cytokine. Role in cardiovascular diseases, diabetes and the metabolic syndrome. Current pharmaceutical design 20 (31):4961-4969","DOI":"10.2174\/1381612819666131206103102"},{"issue":"2","key":"1349_CR46","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1159\/000070180","volume":"55","author":"M Krotkiewski","year":"2003","unstructured":"Krotkiewski M, Landin K, Dahlgren E, Janson PO, Holm G (2003) Effect of two modes of antiandrogen treatment on insulin sensitivity and serum leptin in women with PCOS. Gynecol Obstet Invest 55(2):88\u201395","journal-title":"Gynecol Obstet Invest"},{"issue":"1","key":"1349_CR47","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1210\/jc.2002-020997","volume":"88","author":"L Morin-Papunen","year":"2003","unstructured":"Morin-Papunen L, Vauhkonen I, Koivunen R, Ruokonen A, Martikainen H, Tapanainen JS (2003) Metformin versus ethinyl estradiol-cyproterone acetate in the treatment of nonobese women with polycystic ovary syndrome: a randomized study. The Journal of Clinical Endocrinology & Metabolism 88(1):148\u2013156","journal-title":"The Journal of Clinical Endocrinology & Metabolism"},{"issue":"7","key":"1349_CR48","first-page":"545","volume":"47","author":"N Sa\u011fs\u00f6z","year":"2002","unstructured":"Sa\u011fs\u00f6z N, Ak\u00e7ay F, Bayram M (2002) Effects of oral contraceptives with low-dose estrogen and desogestrel on leptin concentrations. J Reprod Med 47(7):545\u2013548","journal-title":"J Reprod Med"},{"issue":"1","key":"1349_CR49","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/S0301-2115(98)00309-1","volume":"83","author":"T Rechberger","year":"1999","unstructured":"Rechberger T, Baranowski W, Postawski K, Jakimiuk AJ, Tomaszewski J, Kulik-Rechberger B, Jakowicki JA (1999) Serum leptin concentrations in women taking oral contraceptives. Eur J Obstet Gynecol Reprod Biol 83(1):105\u2013108","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"4","key":"1349_CR50","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1210\/jc.2003-031281","volume":"89","author":"L Ibanez","year":"2004","unstructured":"Ibanez L, de Zegher F (2004) Ethinylestradiol-drospirenone, flutamide-metformin, or both for adolescents and women with hyperinsulinemic hyperandrogenism: opposite effects on adipocytokines and body adiposity. The Journal of Clinical Endocrinology & Metabolism 89(4):1592\u20131597","journal-title":"The Journal of Clinical Endocrinology & Metabolism"},{"issue":"12","key":"1349_CR51","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1172\/JCI200319246","volume":"112","author":"SP Weisberg","year":"2003","unstructured":"Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW (2003) Obesity is associated with macrophage accumulation in adipose tissue. J Clin Investig 112(12):1796\u20131808","journal-title":"J Clin Investig"},{"issue":"4","key":"1349_CR52","doi-asserted-by":"publisher","first-page":"2282","DOI":"10.1210\/jc.2004-1696","volume":"90","author":"JM Bruun","year":"2005","unstructured":"Bruun JM, Lihn AS, Pedersen SB, Richelsen B (2005) Monocyte chemoattractant protein-1 release is higher in visceral than subcutaneous human adipose tissue (AT): implication of macrophages resident in the AT. The Journal of clinical endocrinology & metabolism 90(4):2282\u20132289","journal-title":"The Journal of clinical endocrinology & metabolism"},{"issue":"10","key":"1349_CR53","doi-asserted-by":"publisher","first-page":"5043","DOI":"10.1210\/jc.2004-0436","volume":"89","author":"P Dandona","year":"2004","unstructured":"Dandona P, Aljada A, Ghanim H, Mohanty P, Tripathy C, Hofmeyer D, Chaudhuri A (2004) Increased plasma concentration of macrophage migration inhibitory factor (MIF) and MIF mRNA in mononuclear cells in the obese and the suppressive action of metformin. J Clin Endocrinol Metab 89(10):5043\u20135047","journal-title":"J Clin Endocrinol Metab"},{"key":"1349_CR54","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.jsbmb.2019.03.018","volume":"190","author":"CAR de Oliveira","year":"2019","unstructured":"de Oliveira CAR, dos Reis Araujo T, de Souza Aguiar G, da Silva Junior JA, Vettorazzi JF, Freitas IN, de Oliveira KM, Boschero AC, Bonfleur ML, Clarke JR (2019) Combined oral contraceptive in female mice causes hyperinsulinemia due to \u03b2-cell hypersecretion and reduction in insulin clearance. J Steroid Biochem Mol Biol 190:54\u201363","journal-title":"J Steroid Biochem Mol Biol"},{"key":"1349_CR55","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.metabol.2017.05.001","volume":"73","author":"M Amiri","year":"2017","unstructured":"Amiri M, Tehrani FR, Nahidi F, Kabir A, Azizi F, Carmina E (2017) Effects of oral contraceptives on metabolic profile in women with polycystic ovary syndrome: a meta-analysis comparing products containing cyproterone acetate with third generation progestins. Metabolism 73:22\u201335","journal-title":"Metabolism"},{"issue":"5","key":"1349_CR56","doi-asserted-by":"publisher","first-page":"396","DOI":"10.3109\/09513590.2015.1006187","volume":"31","author":"R Yildizhan","year":"2015","unstructured":"Yildizhan R, Gokce AI, Yildizhan B, Cim N (2015) Comparison of the effects of chlormadinone acetate versus drospirenone containing oral contraceptives on metabolic and hormonal parameters in women with PCOS for a period of two-year follow-up. Gynecol Endocrinol 31(5):396\u2013400","journal-title":"Gynecol Endocrinol"},{"issue":"4","key":"1349_CR57","doi-asserted-by":"publisher","first-page":"920","DOI":"10.2337\/dc09-1825","volume":"33","author":"MC Amato","year":"2010","unstructured":"Amato MC, Giordano C, Galia M, Criscimanna A, Vitabile S, Midiri M, Galluzzo A (2010) Visceral Adiposity Index: a reliable indicator of visceral fat function associated with cardiometabolic risk. Diabetes Care 33(4):920\u2013922","journal-title":"Diabetes Care"},{"issue":"6","key":"1349_CR58","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1038\/ijo.2013.181","volume":"38","author":"T Du","year":"2014","unstructured":"Du T, Sun X, Huo R, Yu X (2014) Visceral adiposity index, hypertriglyceridemic waist and risk of diabetes: the China Health and Nutrition Survey 2009. Int J Obes 38(6):840\u2013847","journal-title":"Int J Obes"},{"issue":"9","key":"1349_CR59","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1038\/oby.2009.453","volume":"18","author":"AG Ioachimescu","year":"2010","unstructured":"Ioachimescu AG, Brennan DM, Hoar BM, Hoogwerf BJ (2010) The lipid accumulation product and all-cause mortality in patients at high cardiovascular risk: a PreCIS database study. Obesity 18(9):1836\u20131844","journal-title":"Obesity"},{"issue":"1","key":"1349_CR60","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s12902-019-0348-5","volume":"19","author":"S Behboudi-Gandevani","year":"2019","unstructured":"Behboudi-Gandevani S, Tehrani FR, Rahmati M, Amiri M, Azizi F (2019) Trend of various adiposity indices in women with and without history of gestational diabetes: a population-based cohort study. BMC Endocr Disord 19(1):24","journal-title":"BMC Endocr Disord"},{"issue":"2","key":"1349_CR61","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1530\/eje.1.01840","volume":"152","author":"K Rautio","year":"2005","unstructured":"Rautio K, Tapanainen J, Ruokonen A, Morin-Papunen L (2005) Effects of metformin and ethinyl estradiol\u2013cyproterone acetate on lipid levels in obese and non-obese women with polycystic ovary syndrome. Eur J Endocrinol 152(2):269\u2013275","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"1349_CR62","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.contraception.2010.02.009","volume":"82","author":"A Kriplani","year":"2010","unstructured":"Kriplani A, Periyasamy AJ, Agarwal N, Kulshrestha V, Kumar A, Ammini AC (2010) Effect of oral contraceptive containing ethinyl estradiol combined with drospirenone vs. desogestrel on clinical and biochemical parameters in patients with polycystic ovary syndrome. Contraception 82(2):139\u2013146","journal-title":"Contraception"},{"issue":"1","key":"1349_CR63","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1093\/humrep\/dez255","volume":"35","author":"M Amiri","year":"2020","unstructured":"Amiri M, Nahidi F, Bidhendi-Yarandi R, Khalili D, Tohidi M, Ramezani Tehrani F (2020) A comparison of the effects of oral contraceptives on the clinical and biochemical manifestations of polycystic ovary syndrome: a crossover randomized controlled trial. Hum Reprod 35(1):175\u2013186","journal-title":"Hum Reprod"},{"issue":"3","key":"1349_CR64","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1080\/13625180400007751","volume":"9","author":"P Villaseca","year":"2004","unstructured":"Villaseca P, Hormaza P, Cardenas I, Oestreicher E, Arteaga E (2004) Ethinylestradiol\/cyproterone acetate in polycystic ovary syndrome: lipid and carbohydrate changes. Eur J Contracept Reprod Health Care 9(3):155\u2013165","journal-title":"Eur J Contracept Reprod Health Care"},{"issue":"4","key":"1349_CR65","doi-asserted-by":"publisher","first-page":"245","DOI":"10.3109\/09513590.2011.613971","volume":"28","author":"A Karabulut","year":"2012","unstructured":"Karabulut A, Demirlenk S, \u015eevket O (2012) Effects of ethinyl estradiol-cyproterone acetate treatment on metabolic syndrome, fat distribution and carotid intima media thickness in polycystic ovary syndrome. Gynecol Endocrinol 28(4):245\u2013248","journal-title":"Gynecol Endocrinol"},{"issue":"1","key":"1349_CR66","doi-asserted-by":"publisher","first-page":"56","DOI":"10.3109\/00016349509009945","volume":"74","author":"L Falsetti","year":"1995","unstructured":"Falsetti L, Pasinetti E (1995) Effects of long-term administration of an oral contraceptive containing ethinylestradiol and cyproterone acetate on lipid metabolism in women with polycystic ovary syndrome. Acta Obstet Gynecol Scand 74(1):56\u201360","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"3","key":"1349_CR67","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/S0010-7824(01)00316-X","volume":"65","author":"J Endrikat","year":"2002","unstructured":"Endrikat J, Klipping C, Cronin M, Gerlinger C, Ruebig A, Schmidt W, D\u00fcsterberg B (2002) An open label, comparative study of the effects of a dose-reduced oral contraceptive containing 20\u00a0\u03bcg ethinyl estradiol and 100\u00a0\u03bcg levonorgestrel on hemostatic, lipids, and carbohydrate metabolism variables. Contraception 65(3):215\u2013221","journal-title":"Contraception"},{"issue":"2","key":"1349_CR68","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1093\/humupd\/dmi046","volume":"12","author":"R Sitruk-Ware","year":"2006","unstructured":"Sitruk-Ware R (2006) New progestagens for contraceptive use. Human Reprod Update 12(2):169\u2013178","journal-title":"Human Reprod Update"}],"updated-by":[{"DOI":"10.1007\/s40618-021-01653-x","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2021,8,17]],"date-time":"2021-08-17T00:00:00Z","timestamp":1629158400000}}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-020-01349-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40618-020-01349-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-020-01349-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,17]],"date-time":"2021-08-17T16:12:57Z","timestamp":1629216777000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40618-020-01349-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,17]]},"references-count":68,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["1349"],"URL":"https:\/\/doi.org\/10.1007\/s40618-020-01349-8","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,17]]},"assertion":[{"value":"3 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2021","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s40618-021-01653-x","URL":"https:\/\/doi.org\/10.1007\/s40618-021-01653-x","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors have no conflict of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Ethics approval was obtained from the ethics committee of Shahid Beheshti University of Medical Sciences, Tehran, Iran. (Ethics Code: IR.SBMU.ENDOCRINE.REC.1397.055).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All procedures performed in human participants were in accordance with the ethical standards of the institutional research committees and with the 1964 Helsinki Declaration and its later amendments ethical standards.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants and\/or animals"}},{"value":"Written informed consent was obtained from all eligible participants, following study content being clearly explained to the subjects by the trial assistant; all research tools, including questionnaires, were completely anonymous.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}}]}}